Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
00013 HUTCHMED
13.620
-0.360-2.58%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(Q3)2021/03/31
Assets
Current assets
Inventory
80.06% 45.93M 80.89% 35.76M -- 25.51M -- 19.76M
Accounts receivable
-- 77.08M 74.6% 83.58M -- -- -- --
Related party payments receivable
-- -- -- -- -- 24.23M -- --
Advance deposits and other receivables
127.39% 73.03M 190.18% 81.04M -- 32.12M -- --
Cash and equivalents
-20.42% 467.5M 60.23% 377.54M -- 587.44M -- 346.13M
Short-term investment
-1.19% 358.7M 217.8% 634.16M -- 363.01M -- 49.94M
Other current assets
-- -- -- -- -- -- -- 27.27M
Special items of current assets
-- -- -- -- -- 58.88M -- 53.13M
Total current assets
-6.32% 1.02B 128.37% 1.21B -- 1.09B -- 496.23M
Non-current assets
Property, plant and equipment
51.05% 44.06M 70.77% 41.28M -- 29.17M -- 26.26M
Interests in Joint Venture
-29.85% 83M -45.18% 76.48M -- 118.32M -- 133.82M
Deferred tax assets
-- -- 520.53% 9.4M -- -- -- --
Other illiquid assets
82.28% 45.04M 6.84% 21.55M -- 24.71M -- 26.97M
Special items of non-current assets
-- -- 48.19% 11.88M -- 9.52M -- 9.85M
Total non-current assets
-5.29% 172.1M -16.96% 160.59M -- 181.72M -- 196.89M
Total assets
-6.17% 1.19B 89.56% 1.37B -- 1.27B -- 693.12M
Liabilities
Current liabilities
Accounts payable
78.88% 51.01M 30.26% 41.18M -- 28.51M -- 28.64M
Tax payable
-- -- 1288.04% 15.55M -- -- -- --
Other payables and accrued expenses
28.63% 233.61M 73.84% 210.84M -- 181.61M -- 150.33M
Bank loans and overdrafts
-- -- -- 26.91M -- 26.88M -- --
Financial lease liabilities-current liabilities
-- -- -- -- -- 3.85M -- 3.97M
Other current liabilities
443.17% 37.25M 292.31% 17.19M -- 6.86M -- 5.58M
Total current liabilities
29.93% 321.86M 96.76% 311.66M -- 247.72M -- 188.52M
Net current assets
-16.96% 700.38M 141.82% 900.42M -- 843.46M -- 307.72M
Total assets less current liabilities
-14.89% 872.48M 87.55% 1.06B -- 1.03B -- 504.6M
Non-current liabilities
Long-term bank loan
-- 418K -- -- -- -- -- 26.87M
Financial lease liabilities-non-current liabilities
-- -- 18.09% 7.16M -- 5.96M -- 6.53M
Deferred tax liability
-- -- -45.39% 2.77M -- -- -- --
Other non-current liabilities
265.99% 20.21M 31.64% 11.56M -- 5.52M -- 6.81M
Total non-current liabilities
79.7% 20.63M -54.06% 21.49M -- 11.48M -- 40.21M
Total liabilities
32.13% 342.48M 62.38% 333.15M -- 259.19M -- 228.72M
Total assets less total liabilities
-15.97% 851.85M 100.31% 1.04B -- 1.01B -- 464.4M
Total equity and non-current liabilities
-14.89% 872.48M 87.55% 1.06B -- 1.03B -- 504.6M
Equity
Share capital
1.89% 86.46M 18.8% 86.45M -- 84.85M -- 72.81M
Retained profit
-49.27% -773.19M -46.86% -610.33M -- -518M -- -456.74M
Special items of shareholders' rights and interests
4.83% 1.49B 82.69% 1.51B -- 1.42B -- 812.2M
Shareholders' Equity
-18.79% 799.73M 103.85% 986.89M -- 984.8M -- 428.27M
Non-controlling interest
80.35% 52.12M 51.07% 52.62M -- 28.9M -- 36.12M
Total equity
-15.97% 851.85M 100.31% 1.04B -- 1.01B -- 464.4M
Total equity and total liabilities
-6.17% 1.19B 89.56% 1.37B -- 1.27B -- 693.12M
Currency Unit
USDUSDUSDUSD
Accounting Standards
UASUASUASUAS
Audit Opinions
--Unqualified Opinion----
Auditor
--PricewaterhouseCoopers----

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.
CEO: Zhiqiang Du
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...